CDC- BRFSS – ACBS 2021 Adult Prevalence Table 6
Updated December 14, 2023
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
Arizona | 350 | 33.7 | 3.5 | (26.8 – 40.6) |
California | 132 | 40.9 | 5.9 | (29.3 – 52.5) |
Connecticut | 348 | 33.1 | 3.8 | (25.7 – 40.5) |
Florida | 201 | 44.4 | 7.5 | (29.7 – 59.1) |
Georgia | 235 | 35.3 | 4.8 | (25.9 – 44.7) |
Hawaii | 175 | 27.0 | 4.8 | (17.6 – 36.4) |
Indiana | 462 | 26.7 | 2.5 | (21.8 – 31.6) |
Iowa | 288 | 32.2 | 3.9 | (24.6 – 39.8) |
Kansas | 449 | 32.7 | 2.9 | (27.0 – 38.4) |
Kentucky | 158 | 40.7 | 5.3 | (30.3 – 51.1) |
Maine | 403 | 33.8 | 4.0 | (26.0 – 41.6) |
Maryland | 344 | 30.9 | 3.4 | (24.2 – 37.6) |
Massachusetts | 253 | 41.3 | 4.0 | (33.5 – 49.1) |
Michigan | 514 | 29.2 | 2.4 | (24.5 – 33.9) |
Minnesota | 491 | 29.8 | 2.7 | (24.5 – 35.1) |
Missouri | 375 | 34.5 | 3.8 | (27.1 – 41.9) |
Montana | 162 | 31.2 | 5.1 | (21.2 – 41.2) |
Nebraska | 380 | 35.3 | 3.6 | (28.2 – 42.4) |
New Hampshire | 400 | 32.0 | 3.3 | (25.5 – 38.5) |
New Jersey | 287 | 27.7 | 4.1 | (19.7 – 35.7) |
New Mexico | 216 | 35.0 | 4.5 | (26.2 – 43.8) |
New York | 596 | 29.9 | 3.3 | (23.4 – 36.4) |
Ohio | 365 | 35.7 | 3.5 | (28.8 – 42.6) |
Oregon | 225 | 26.7 | 3.5 | (19.8 – 33.6) |
Pennsylvania | 167 | 28.3 | 4.8 | (18.9 – 37.7) |
Rhode Island | 346 | 29.0 | 3.2 | (22.7 – 35.3) |
Texas | 341 | 24.2 | 3.7 | (16.9 – 31.5) |
Utah | 343 | 26.9 | 3.4 | (20.2 – 33.6) |
Vermont | 374 | 30.2 | 3.3 | (23.7 – 36.7) |
Wisconsin | 293 | 28.5 | 3.7 | (21.2 – 35.8) |
30 States / Area | 9,673 | 32.7 | 1.1 | (30.5 – 34.9) |
Median | 31.6 | |||
Range | 24.2-44.4 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2021/pdf/sdq_report_acbs_21-508.pdf